Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by TheKneeHon Mar 09, 2020 2:01pm

103 Views

Post# 30784251

RE:IIROC

bud13 wrote:
just wondering if anyone here has put in a complaint and concerns around this deal purposed. This deal is problematic to me as it stands. Looks like all the players involved are taking the current shareholders to the cleaners. Just a thought

This deal definitely smells. The 12-1 was rejected a while ago, and now they want to go with a 100-1.

The only plausible way I see this deal getting through is if some entity (Stero?) becomes a majority shareholder, which would render our vote useless.

According to the terms, David Bassa (current CEO of Stero) would become the CEO of Kaly (no word on what becomes of Farrell). It's worth remembering that Bassa was the CEO of Talent Biotech (the GvHD company acquired by Kaly in 2017).......seems like the same players are always involved -- even Dr. Sagiv and Dr. Yeshurun are involved in all 3 companies.

Feels like we're being played.

Bullboard Posts

Eminent acquires promising Nevada gold project